about
Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsisFibrinolytic and coagulative activities of Yersinia pestisVenous thrombosis among patients with AIDSInflammatory and coagulation biomarkers and mortality in patients with HIV infectionActivation of coagulation and fibrinolysis during dengue virus infection.Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infectionKinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection.Serum amyloid A and clusterin as potential predictive biomarkers for severe hand, foot and mouth disease by 2D-DIGE proteomics analysis.Tumor necrosis factor alpha and gamma interferon, but not hemorrhage or pathogen burden, dictate levels of protective fibrin deposition during infectionM type 1 and 3 group A streptococci stimulate tissue factor-mediated procoagulant activity in human monocytes and endothelial cells.Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens.Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.Interactions between coagulation and inflammation.Influenza and cardiovascular disease: is there a causal relationship?Serum levels of soluble vascular cell adhesion molecules may correlate with the severity of dengue virus-1 infection in adults.Impact of the Pla protease substrate α2-antiplasmin on the progression of primary pneumonic plague.Intraoperative bleeding in dogs from Grenada seroreactive to Anaplasma platys and Ehrlichia canis.Review: Viral infections and mechanisms of thrombosis and bleeding.Effective treatment with a new protocol using tissue-type plasminogen activator thrombolysis for pump thrombosis with the HVAD device.Proteolysis of plasminogen activator inhibitor-1 by Yersinia pestis remodulates the host environment to promote virulencePrognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever.Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever.Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever.Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C.Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.Structural Principles in the Development of Cyclic Peptidic Enzyme Inhibitors.Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated).Thrombin-activatable fibrinolysis inhibitor binds to Streptococcus pyogenes by interacting with collagen-like proteins A and B.Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.Stimulation of blood mononuclear cells with bacterial virulence factors leads to the release of pro-coagulant and pro-inflammatory microparticles.
P2860
Q24794692-192FD3D2-B7FE-42B7-B67D-D340D29C4A3EQ26862503-5CDC1E97-0910-4200-984D-14C12C2B277FQ28167369-E54A67C3-4C6C-4937-936A-ABAAFEE10DFAQ28473903-F327DB88-6E28-48B5-B66E-AAE901930813Q33335829-769A9AD3-5FB5-4685-8A97-B329FD61B07DQ33404448-7825C58D-380D-4872-80C4-9BB00B034240Q33857515-E516C502-A52C-4CA0-ABDF-830469DEBE3AQ33974253-B4619F36-C1AA-4C91-9B39-790F756B0E43Q34277441-457D6BB9-AA6D-45B7-955A-D0E72FE88AEEQ34334346-4D5B972B-7DFD-4B2C-B536-F6D14F27E97FQ34851150-7D44AD84-CAA9-4A75-838E-128E449D0A60Q35139775-CDD9B57C-F595-41C6-8ACE-2864206F3F43Q35176262-6321FBE2-5F99-4E1A-A7FB-AF525620D327Q35585029-373D3080-483E-47A0-B0E5-BD9A6D804E0AQ35733937-993B5E79-BD04-45C8-AB91-2704F838B49FQ36073685-3FF15522-E6FB-4C61-8C12-C2CB0D0A578AQ36281274-377BFFCB-66C3-499C-A924-9F5D3CED7D48Q36975524-5FE31120-B87F-417E-9ED8-A462B92DEEFFQ38038832-33548810-9250-4FF3-A3D7-ED43AF136E1DQ39036756-4100179B-52F4-49F3-85E7-E3D1023007C6Q39633118-A1ED8286-1B7C-4B7E-A237-652A644F4389Q40316856-94979960-238E-49D4-9455-ACD4D819E93FQ40578868-30E9B4BE-62CD-45E2-A6BB-9923CA2192D2Q40603732-3894DBFC-2991-41DE-9CDA-0F39DE7AC3E4Q40711044-881C4294-D4F0-4EBF-9673-8870230B0619Q42588928-9297365D-D219-403E-A205-FC60E50C8C60Q47098588-1207D68D-D760-48EC-9412-12D4BBAA1206Q47799201-BE61C073-AE37-4682-A235-7748573A9BB4Q48078999-FE7DE55F-94CF-4E60-8759-AE0AFE4FE840Q51955997-99E761FD-431C-4B53-96D2-E6DB1F2D1DD1Q53216740-868929B0-C032-47DE-AEB3-97356903ABEE
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Review: infectious diseases and coagulation disorders.
@ast
Review: infectious diseases and coagulation disorders.
@en
Review: infectious diseases and coagulation disorders.
@nl
type
label
Review: infectious diseases and coagulation disorders.
@ast
Review: infectious diseases and coagulation disorders.
@en
Review: infectious diseases and coagulation disorders.
@nl
prefLabel
Review: infectious diseases and coagulation disorders.
@ast
Review: infectious diseases and coagulation disorders.
@en
Review: infectious diseases and coagulation disorders.
@nl
P2093
P356
P1476
Review: infectious diseases and coagulation disorders.
@en
P2093
Brandjes DP
Dolmans WM
ten Cate H
ten Cate JW
van Gorp EC
van der Meer JW
P304
P356
10.1086/314829
P407
P577
1999-07-01T00:00:00Z